Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrik Lassen

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
Socioeconomic Differences in Referral to Phase I Cancer Clinical Trials: A Danish Matched Cancer Case-Control StudyKatrine Toubro Gad, Christoffer Johansen, Anne Katrine Duun-Henriksen, et al.
The International Journal of Neuroscience|September 15, 2015
Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case seriesMikkel Christian Alanin, Camilla Klausen, Per Caye-Thomasen, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 26, 2014
The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2Mikkel Christian Alanin, Camilla Klausen, Per Caye-Thomasen, et al.
Plos One|February 14, 2015
18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastomaMette Kjoelhede Nedergaard, Signe Regner Michaelsen, Thomas Urup, et al.
Cytotherapy|March 24, 2020
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcomeVinicius Araujo B de Lima, Annie Borch, Morten Hansen, et al.
Cancers|April 12, 2022
Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion CancersJesus Garcia-Foncillas, Carsten Bokemeyer, Antoine Italiano, et al.
Acta Oncologica (Stockholm, Sweden)|March 22, 2013
Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: outcome and results of KRAS mutational analysis in plasmaKaren-Lise G Spindler, Morten M Sorensen, Niels Pallisgaard, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 30, 2010
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecanBenedikte Hasselbalch, Jesper Grau Eriksen, Helle Broholm, et al.
The Oncologist|May 8, 2025
Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patientsMorten Ladekarl, Mette Louise Mørk, Emma Skotte Albertsen, et al.
Cancer Genetics|May 28, 2025
HRD status variation in consecutive tumour biopsies in a pan-cancer cohort: a descriptive single-center study including patients from the Phase 1 Unit, Copenhagen University Hospital, RigshospitaletRosa Damkjær Britton, Daniela Alosi, Luca Robinson, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
Socioeconomic Differences in Referral to Phase I Cancer Clinical Trials: A Danish Matched Cancer Case-Control StudyKatrine Toubro Gad, Christoffer Johansen, Anne Katrine Duun-Henriksen, et al.
The International Journal of Neuroscience|September 15, 2015
Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case seriesMikkel Christian Alanin, Camilla Klausen, Per Caye-Thomasen, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 26, 2014
The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2Mikkel Christian Alanin, Camilla Klausen, Per Caye-Thomasen, et al.
Plos One|February 14, 2015
18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastomaMette Kjoelhede Nedergaard, Signe Regner Michaelsen, Thomas Urup, et al.
Cytotherapy|March 24, 2020
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcomeVinicius Araujo B de Lima, Annie Borch, Morten Hansen, et al.
Cancers|April 12, 2022
Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion CancersJesus Garcia-Foncillas, Carsten Bokemeyer, Antoine Italiano, et al.
Acta Oncologica (Stockholm, Sweden)|March 22, 2013
Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: outcome and results of KRAS mutational analysis in plasmaKaren-Lise G Spindler, Morten M Sorensen, Niels Pallisgaard, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 30, 2010
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecanBenedikte Hasselbalch, Jesper Grau Eriksen, Helle Broholm, et al.
The Oncologist|May 8, 2025
Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patientsMorten Ladekarl, Mette Louise Mørk, Emma Skotte Albertsen, et al.
Cancer Genetics|May 28, 2025
HRD status variation in consecutive tumour biopsies in a pan-cancer cohort: a descriptive single-center study including patients from the Phase 1 Unit, Copenhagen University Hospital, RigshospitaletRosa Damkjær Britton, Daniela Alosi, Luca Robinson, et al.
Pageof 16